Novel Antimicrobial Treatment in Burn Graft Biomaterials

Information

  • Research Project
  • 6944020
  • ApplicationId
    6944020
  • Core Project Number
    R44GM064847
  • Full Project Number
    5R44GM064847-03
  • Serial Number
    64847
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/1/2002 - 22 years ago
  • Project End Date
    8/31/2007 - 17 years ago
  • Program Officer Name
    FILART, ROSEMARIE
  • Budget Start Date
    9/1/2005 - 19 years ago
  • Budget End Date
    8/31/2007 - 17 years ago
  • Fiscal Year
    2005
  • Support Year
    3
  • Suffix
  • Award Notice Date
    9/8/2005 - 19 years ago
Organizations

Novel Antimicrobial Treatment in Burn Graft Biomaterials

[unreadable] DESCRIPTION (provided by applicant): [unreadable] Burn injuries represent the most terrifying and horrific trauma imaginable. This image is conditioned, in part, from the appearance of surviving bum victims that have been horribly scarred and disfigured following the healing of their injuries. Fortunately significant advances have been made that prevent these outcomes. Conventional rescue, first aid and emergency trauma have significantly improved survival of badly burned individuals. Moreover, surgical intervention and tissue repair products have greatly improved the quality of healed tissues. A notable improvement is the use of implantable collagen matrices that serve as tissue scaffolding to support the formation of neodermis. This improvement significantly decreases contraction and provides an optimal bed for split thickness grafts which overall significantly shorten healing times and improve cosmetic appearance. However collagen matrices are uniquely susceptible to colonization with bacteria because they are largely devoid of humoral and cellular defense mechanisms. Microbial colonization invariably necessitates removal of the collagen matrix, antimicrobial therapy, and repeat surgical applications. We have shown in Phase I studies that it is practical to impregnate collagen matrix with antimicrobial silver to render it inherently resistant to colonization. This phase II application proposes to extend those findings to optimize the silver impregnation protocol so as to improve collagen matrix implant materials for use in burn and deep tissue repairs and test their efficacy in an in vivo wound model. The ultimate goal of this project is to produce commercially viable silver impregnated collagen matrix that resists microbial contamination. [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    335557
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:335557\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ACRYMED, INC.
  • Organization Department
  • Organization DUNS
    878062256
  • Organization City
    BEAVERTON
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    97008
  • Organization District
    UNITED STATES